Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Vorbipiprant sodium by Rottapharm Biotech for Gastrointestinal Tumor: Likelihood of Approval
Vorbipiprant sodium is under clinical development by Rottapharm Biotech and currently in Phase II for Gastrointestinal Tumor. According to GlobalData,...
Data Insights
Vorbipiprant sodium by Rottapharm Biotech for Adenocarcinoma Of The Gastroesophageal Junction: Likelihood of Approval
Vorbipiprant sodium is under clinical development by Rottapharm Biotech and currently in Phase II for Adenocarcinoma Of The Gastroesophageal Junction....